ニュース

Samsung Biologics, C&T Shares Volatile After Spin-Off Plan
Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will ...
Samsung Biologics splits biosimilar business to boost CDMO, investment flexibility
Samsung Biologics, the biotech arm of Samsung Group, announced Thursday that it will spin off its biosimilar operations into ...
South Korea's Samsung BioLogics says it plans to separate company
South Korean drug maker Samsung BioLogics said on Thursday it plans to split its business into contract manufacturing and development companies, to help allay customer concerns about conflicts of ...
Yonhap News (English) on MSN1 日
Samsung Biologics plans to separate CDMO, biosimilar biz
Seoul: Samsung Biologics, a biotech arm of South Korea's Samsung Group, said on Thursday it plans to spin off its biosimilar ...
Samsung BioLogics spin-off to separate contract drug making, new growth drivers
South Korean drug maker Samsung BioLogics said on Thursday it plans to split its business into contract manufacturing and development companies, to help allay customer concerns about conflicts of ...
Fierce Pharma1 日
CDMO Samsung Biologics telegraphs spinoff of biosim unit
In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its ...
Yonhap News Agency on MSN2 日
Samsung Biologics plans to set up holding company to separate CDMO, biosimilar biz
According to a regulatory filing, the company will establish a new entity, Samsung Epis Holdings, which will later ...